Log In
Print
BCIQ
Print
Print this Print this
 

Curaxin, quinacrine (CBL0102) (formerly CBLC102)

  Manage Alerts
Collapse Summary General Information
Company Cleveland BioLabs Inc.
DescriptionAnticancer compound from the Curaxin family that targets p53 and NF-kappa B (NF-kB)
Molecular Target p53 ; NF-kappa B (NF-kB)
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today